GLICLAZIDE GH MR gliclazide 60 mg modified release tablet blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

gliclazide, Quantity: 60 mg

Pieejams no:

Lupin Australia Pty Limited

Zāļu forma:

Tablet, modified release

Kompozīcija:

Excipient Ingredients: hypromellose; povidone; calcium hydrogen phosphate dihydrate; magnesium stearate

Ievadīšanas:

Oral

Vienības iepakojumā:

20 tablets, 60 tablets

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Produktu pārskats:

Visual Identification: White to off-white oval shaped, bioconvex, uncoated tablet with a break line on both sides and debossed wtih 60 on one side of the break line on one surface.and plain on the other side; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Registered

Autorizācija datums:

2022-11-14